Kiwa Bio-Tech (KWBT) stock price, revenue, and financials

Kiwa Bio-Tech market cap is $439.2 k, and annual revenue was $30.65 m in FY 2018

$439.2 K

KWBT Mkt cap, 08-Jan-2020

$11 M

Kiwa Bio-Tech Revenue Q3, 2019
Kiwa Bio-Tech Gross profit (Q3, 2019)2.6 M
Kiwa Bio-Tech Gross profit margin (Q3, 2019), %23.5%
Kiwa Bio-Tech Net income (Q3, 2019)311.2 K
Kiwa Bio-Tech EBIT (Q3, 2019)1.9 M
Kiwa Bio-Tech Cash, 30-Sept-20192 M
Kiwa Bio-Tech EV-1.3 M

Kiwa Bio-Tech Income Statement

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

9.6m17.3m30.7m

Cost of goods sold

7.2m11.8m22.4m

Gross profit

2.4m5.4m8.3m

Gross profit Margin, %

25%31%27%

Sales and marketing expense

530.3k483.0k617.4k

R&D expense

166.7k159.1k162.8k162.7k179.0k149.2k148.0k122.8k

General and administrative expense

1.3m1.0m394.1k364.8k313.6k868.8k3.0m4.9m

Operating expense total

1.4m1.2m556.9k527.6k492.6k1.5m3.6m5.7m

EBIT

(1.4m)(1.2m)(556.9k)(527.6k)(492.6k)872.7k1.8m2.6m

EBIT margin, %

9%10%8%

Interest expense

268.5k253.2k187.7k184.8k593.7k120.9k339.3k

Interest income

Pre tax profit

(268.5k)(1.5m)3.7m(617.6k)(677.4k)1.5m1.9m2.3m

Income tax expense

424.9k(1.1m)(1.9m)

Net Income

(1.7m)(1.3m)3.7m(617.6k)(677.4k)891.0k5.3m343.8k

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Revenue

267.0k443.1k1.3m31.0k8.8m5.3m7.7m9.5m10.9m11.0m

Cost of goods sold

770.5k19.7k6.3m3.9m5.5m7.4m7.8m8.4m

Gross profit

491.1k11.3k2.4m1.5m2.3m2.2m3.2m2.6m

Gross profit Margin, %

39%37%28%27%29%23%29%23%

Sales and marketing expense

36.3k54.2k147.8k184.3k161.3k36.7k37.8k63.5k37.9k

R&D expense

40.3k39.7k39.8k39.5k39.8k40.2k40.6k40.9k41.0k40.1k40.7k40.7k40.9k39.9k77.0k74.8k74.8k36.3k36.4k37.5k39.3k39.2k64.1k

General and administrative expense

334.7k245.7k246.4k243.7k262.0k253.3k253.5k268.9k86.4k85.8k82.7k79.0k68.6k73.0k86.9k138.8k196.0k394.3k625.3k1.1m1.6m1.5m961.5k959.6k1.4m686.7k

Operating expense total

375.0k285.4k286.2k283.2k301.7k293.5k294.1k309.8k127.3k125.9k123.4k119.7k109.5k112.8k163.9k213.6k270.8k466.9k715.9k1.3m1.8m1.7m1.1m997.4k3.9m724.6k

EBIT

(375.0k)(285.4k)(286.2k)(283.2k)(301.7k)(293.5k)(294.1k)(309.8k)(127.3k)(125.9k)(123.4k)(119.7k)(109.5k)(112.8k)103.1k229.5k220.3k(466.9k)(715.9k)(1.2m)657.3k(253.5k)1.2m1.2m(743.2k)1.9m

EBIT margin, %

39%52%17%(4004%)8%(5%)16%12%(7%)17%

Interest expense

78.2k64.1k63.2k63.2k63.6k61.6k62.0k57.7k6.1k5.8k5.7k23.9k47.0k47.5k47.7k61.8k148.0k391.5k64.4k23.8k73.3k267.5k788.5k1.3m

Interest income

Pre tax profit

(453.2k)(349.5k)(349.4k)(346.3k)(252.3k)(355.1k)(356.1k)4.6m(149.4k)(148.3k)(145.9k)(142.8k)(133.0k)(136.7k)56.1k182.0k172.5k(528.7k)(863.9k)(850.9k)592.9k(277.3k)1.1m911.5k(1.5m)563.1k

Income tax expense

78.9k51.4k47.8k(123.1k)(539.3k)(358.1k)(514.4k)(520.9k)714.0k(251.9k)

Net Income

(453.2k)(349.5k)(349.4k)(346.3k)(252.3k)(355.1k)(356.1k)4.6m(149.4k)(148.3k)(145.9k)(142.8k)(133.0k)(136.7k)56.1k182.0k93.6k(491.5k)3.7m(727.8k)53.6k(635.4k)623.4k390.6k(2.2m)311.2k

Kiwa Bio-Tech Balance Sheet

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

16.3k4.5k2.0k3.0k721.013.5k1.1m7.9k

Accounts Receivable

1.1m28.6k6.8m

Prepaid Expenses

2.5m2.3m

Inventories

2.7m1.6m

Current Assets

42.7k26.1k16.5k17.2k48.2k4.6m19.1m31.7m

PP&E

20.3k16.0k12.0k7.4k2.8k59.8k90.5k93.2k

Goodwill

34.1k

Total Assets

63.0k42.0k28.5k24.6k51.0k4.7m20.0m32.5m

Accounts Payable

307.3k312.6k321.7k316.8k300.2k1.3m1.8m1.6m

Short-term debt

360.0k360.0k360.0k360.0k

Current Liabilities

10.6m12.0m8.4m9.0m9.4m10.3m8.9m19.8m

Long-term debt

1.8m1.8m1.9m1.9m1.8m360.0k

Non-Current Liabilities

1.8m

Total Debt

1.8m1.8m150.3k150.3k720.0k720.0k720.0k720.0k

Total Liabilities

12.4m13.8m10.3m10.8m11.2m9.3m19.8m

Common Stock

400.0k400.0k400.0k400.0k2.0k15.2k16.9k

Preferred Stock

500.0

Additional Paid-in Capital

8.1m8.1m8.1m8.1m9.5m13.8m24.5m27.0m

Retained Earnings

(20.4m)(21.7m)(18.0m)(18.6m)(20.3m)(19.5m)(14.6m)(14.8m)

Total Equity

(12.3m)(13.8m)(10.3m)(10.8m)(11.1m)(5.6m)10.7m12.7m

Debt to Equity Ratio

0 x0 x-0.1 x-0.1 x0.1 x0.1 x

Debt to Assets Ratio

5.3 x6.1 x14.1 x0.2 x0 x0 x

Financial Leverage

0 x0 x0 x0 x0 x-0.8 x1.9 x2.6 x

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

18.0k4.2k4.8k4.3k13.6k89.4k4.9k4.6k6.0k11.3k4.3k667.0856.03.1k42.6k12.4k545.0140.1k71.6k23.3k61.8k5.1m11.1k356.8k10.1k2.0m

Accounts Receivable

41.2k55.2k1.2m3.8m9.4m15.2m24.1k7.0m6.8m7.1m3.5m3.5m

Prepaid Expenses

1.6m1.3m1.2m1.2m3.7m3.1m2.9m1.9m1.8m1.4m

Inventories

10.8k13.6m1.7m1.6m117.3k114.6k141.4k

Current Assets

44.8k30.5k31.5k30.8k40.0k103.5k19.2k16.5k20.1k25.4k18.6k15.0k15.2k16.9k285.2k1.3m4.6m8.5m19.6m30.8m24.2m28.6m29.9m35.0m31.4m32.3m

PP&E

22.9k22.1k19.2k17.8k16.9k14.9k14.0k12.9k10.5k9.5k8.5k6.3k5.2k3.9k1.8k77.2k69.7k46.3k41.7k84.5k75.2k63.8k54.9k89.7k117.8k69.8k

Goodwill

34.1k34.1k

Total Assets

67.7k52.6k50.7k48.6k56.9k118.5k33.2k29.4k30.7k34.9k27.1k21.3k20.4k20.8k321.1k1.4m4.7m10.2m20.5m32.0m25.2m29.5m30.7m35.9m32.2m33.1m

Accounts Payable

336.7k342.9k309.2k306.5k309.8k313.5k317.3k318.2k313.3k313.9k317.3k318.2k318.8k306.0k324.4k342.3k1.1m1.1m4.7m8.9m3.5m880.3k1.2m2.1m2.6m2.3m

Short-term debt

360.0k360.0k360.0k360.0k360.0k360.0k360.0k360.0k360.0k138.0k138.0k138.0k

Current Liabilities

9.7m10.2m11.0m11.3m11.6m12.5m12.8m8.2m8.4m8.6m8.8m9.1m9.3m9.2m6.5m7.1m8.0m13.9m19.6m29.7m11.7m16.8m18.2m20.6m19.1m19.5m

Long-term debt

1.8m1.8m1.8m1.8m1.8m1.9m1.9m1.9m1.8m1.9m1.9m1.9m1.9m1.8m1.8m1.7m1.7m32.9k

Non-Current Liabilities

1.8m1.8m1.8m1.7m1.7m32.9k

Total Debt

1.8m1.8m1.8m1.8m1.8m1.9m1.9m150.3k150.3k150.3k150.3k150.3k150.3k150.3k720.0k720.0k720.0k720.0k720.0k720.0k720.0k720.0k720.0k276.0k276.0k276.0k

Total Liabilities

11.5m12.0m12.8m13.1m13.4m14.3m14.7m10.1m10.3m10.5m10.7m11.0m11.2m11.0m8.3m8.8m9.8m19.8m30.1m12.2m17.4m18.2m20.6m19.1m19.6m

Common Stock

400.0k400.0k400.0k400.0k400.0k400.0k400.0k400.0k400.0k400.0k400.0k400.0k400.0k400.0k5.1k5.4k8.6k9.8k10.0k11.2k16.1k16.6k16.9k18.9k19.5k19.9k

Preferred Stock

500.0500.0500.0500.0500.0500.01.3k1.3k

Additional Paid-in Capital

8.1m8.1m8.1m8.1m8.1m8.1m8.1m8.1m8.1m8.1m8.1m8.1m8.1m8.1m12.6m12.8m15.7m16.3m16.9m18.7m26.2m26.7m27.1m28.8m29.3m30.1m

Retained Earnings

(19.6m)(20.0m)(20.7m)(21.1m)(21.3m)(22.1m)(22.4m)(17.8m)(18.1m)(18.3m)(18.4m)(18.8m)(18.9m)(19.0m)(20.3m)(20.1m)(20.0m)(20.1m)(16.4m)(17.1m)(14.5m)(15.2m)(14.5m)(14.4m)(16.7m)(16.3m)

Total Equity

(11.4m)(11.9m)(12.7m)(13.0m)(13.3m)(14.2m)(14.6m)(10.1m)(10.3m)(10.4m)(10.6m)(11.0m)(11.1m)(10.9m)(7.9m)(7.5m)(5.0m)(3.7m)674.9k1.9m13.0m12.1m12.5m15.2m13.1m13.6m

Debt to Equity Ratio

0 x0 x0 x0 x0 x0 x0 x-0.1 x-0.1 x-0.1 x-0.2 x1.1 x0.4 x0.1 x0.1 x0.1 x0 x0 x0 x

Debt to Assets Ratio

5.1 x4.9 x4.3 x5.5 x7.1 x7.4 x7.2 x2.2 x0.5 x0.2 x0.1 x0 x0 x0 x0 x0 x0 x0 x0 x

Financial Leverage

0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x-0.2 x-0.9 x-2.7 x30.4 x17.2 x1.9 x2.4 x2.5 x2.4 x2.5 x2.4 x

Kiwa Bio-Tech Cash Flow

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(1.7m)(1.3m)3.7m(617.6k)(677.4k)891.0k5.3m343.8k

Depreciation and Amortization

6.8k4.7k4.5k4.4k4.4k21.2k46.5k27.9k

Accounts Receivable

(33.9k)(1.2m)1.1m(7.0m)

Inventories

(2.6m)994.5k

Accounts Payable

(26.4k)1.1m631.3k(97.1k)

Cash From Operating Activities

(499.8k)(242.7k)(138.0k)(143.3k)(150.2k)(908.7k)(5.6m)(1.6m)

Purchases of PP&E

(79.1k)(75.3k)(53.0k)

Cash From Investing Activities

(79.1k)(815.1k)(53.0k)

Long-term Borrowings

Cash From Financing Activities

448.9k236.4k124.1k144.2k148.0k1.0m7.5m559.8k

Net Change in Cash

(16.5k)(11.8k)(2.5k)924.0(2.2k)13.0k1.1m(1.1m)

Interest Paid

Income Taxes Paid

460.9k

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Net Income

(929.9k)(1.3m)(349.4k)(695.7k)(948.0k)(355.1k)(711.2k)3.9m(149.4k)(297.7k)(443.7k)(142.8k)(275.8k)(412.6k)56.1k238.1k331.7k(491.5k)3.2m2.5m53.6k(582.4k)41.0k390.6k(1.9m)(1.5m)

Depreciation and Amortization

3.6k4.9k1.3k2.5k3.7k1.1k2.2k3.3k1.1k2.2k3.3k1.1k2.2k3.3k1.0k3.1k13.0k9.5k17.8k29.5k19.6k20.5k24.4k5.7k10.6k33.7k

Accounts Receivable

40.6k54.9k(1.2m)(2.6m)(8.2m)(14.0m)5.5k(7.2m)(7.1m)(211.0k)(151.5k)(252.7k)

Inventories

(10.6k)(10.6m)1.0m1.0m1.6m1.5m1.5m

Accounts Payable

17.4k10.1k50.0k794.9k7.8k3.6m7.6m1.6m(926.1k)(504.4k)427.7k948.7k719.4k

Cash From Operating Activities

(348.9k)(400.0k)(124.7k)(162.5k)(217.4k)(20.9k)(82.3k)(106.6k)(58.0k)(92.5k)(113.5k)(5.2k)(55.0k)(77.9k)1.4k(148.9k)(737.8k)(1.0m)(2.3m)(3.4m)(1.2m)3.8m(1.5m)(539.9k)(1.5m)305.1k

Purchases of PP&E

(79.6k)(2.3k)(58.4k)(1.9k)(3.5k)(4.8k)(38.9k)(3.9k)

Cash From Investing Activities

(78.8k)(79.6k)(147.8k)(793.0k)(1.9k)(3.5k)(4.8k)(38.9k)(3.9k)

Long-term Borrowings

Cash From Financing Activities

428.2k387.3k110.9k147.0k203.6k105.9k55.9k108.9k62.0k100.0k115.8k2.9k52.9k78.0k38.5k216.5k817.8k1.2m2.5m4.2m99.3k444.7k542.8k936.6k994.5k1.2m

Net Change in Cash

(14.8k)(28.6k)(11.5k)(12.0k)(2.7k)84.9k441.0132.04.0k9.2k2.3k(2.3k)(2.1k)117.041.9k11.6k(176.0)126.6k58.1k9.8k(1.0m)4.0m(1.1m)348.9k2.2k2.0m

Interest Paid

Income Taxes Paid

444.3k457.6k3.8k

Kiwa Bio-Tech Ratios

USDY, 2019

EV/EBIT

-0.7 x

EV/CFO

-4.3 x

Financial Leverage

2.4 x